Pegasus Partners Ltd. buys $2,508,300 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Pegasus Partners Ltd. scooped up 195 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 9, 2016. The investment management firm now holds a total of 30,000 shares of Cardinal Health Inc which is valued at $2,508,300.Cardinal Health Inc makes up approximately 1.25% of Pegasus Partners Ltd.’s portfolio.

Other Hedge Funds, Including , Coldstream Capital Management Inc boosted its stake in CAH in the latest quarter, The investment management firm added 229 additional shares and now holds a total of 20,899 shares of Cardinal Health Inc which is valued at $1,747,365. Cardinal Health Inc makes up approx 0.30% of Coldstream Capital Management Inc’s portfolio.Airain Ltd reduced its stake in CAH by selling 38,867 shares or 45.75% in the most recent quarter. The Hedge Fund company now holds 46,085 shares of CAH which is valued at $3,887,731. Cardinal Health Inc makes up approx 0.22% of Airain Ltd’s portfolio.Coconut Grove Bank boosted its stake in CAH in the latest quarter, The investment management firm added 60 additional shares and now holds a total of 260 shares of Cardinal Health Inc which is valued at $21,934. Cardinal Health Inc makes up approx 0.02% of Coconut Grove Bank’s portfolio.Nisa Investment Advisors boosted its stake in CAH in the latest quarter, The investment management firm added 49,927 additional shares and now holds a total of 150,148 shares of Cardinal Health Inc which is valued at $12,493,815. Cardinal Health Inc makes up approx 0.16% of Nisa Investment Advisors’s portfolio.

Cardinal Health Inc opened for trading at $82.88 and hit $82.99 on the upside on Wednesday, eventually ending the session at $82.78, with a gain of 0.12% or 0.1 points. The heightened volatility saw the trading volume jump to 14,91,923 shares. Company has a market cap of $26,373 M.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.